Conjugation of MCR1 ligand with cytotoxic drugs for treating skin cancer
US-12440570-B2 · Oct 14, 2025 · US
Alpha-melanotropin
Alpha-melanotropin · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/685 |
| Official title | Alpha-melanotropin |
| Display label | Alpha-melanotropin |
| Total patents | 53 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 11 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
US-12303555-B2 · May 20, 2025 · US
Cyclic peptide analogs of melanocortin and amanitin and methods of making such
US-11884714-B2 · Jan 30, 2024 · US
Nucleic acid construct
US-11613559-B2 · Mar 28, 2023 · US
Cyclic peptide analogs of melanocortin and amanitin and methods of making such
US-2022298219-A1 · Sep 22, 2022 · US
Engineered nucleic acids and methods of use thereof
US-2022273766-A1 · Sep 1, 2022 · US
Cyclic peptide analogs of melanocortin and amanitin and methods of making such
US-11396535-B2 · Jul 26, 2022 · US
Conjugation of mcr1 ligand with cytotoxic drugs for treating skin cancer
US-2022143196-A1 · May 12, 2022 · US
Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
US-2022062387-A1 · Mar 3, 2022 · US
Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
US-11202820-B2 · Dec 21, 2021 · US
Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
US-11160887-B2 · Nov 2, 2021 · US
Modulators of melanocortin receptors
US-11124542-B2 · Sep 21, 2021 · US
Method of treating melanocortin-4 receptor pathway-associated disorders
US-2021169970-A1 · Jun 10, 2021 · US
Cyclic peptide analogs of melanocortin and amanitin and methods of making such
US-2021024605-A1 · Jan 28, 2021 · US
Bicyclic Compounds Capable of Binding to Melanocortin 4 Receptor
US-2020223889-A1 · Jul 16, 2020 · US
Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
US-10653743-B2 · May 19, 2020 · US
Compositions and methods for treating central nervous system (CNS) disorders and mood disorders
US-10550157-B2 · Feb 4, 2020 · US
Novel modulators of melanocortin receptors
US-2019309022-A1 · Oct 10, 2019 · US
Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
US-2019282716-A1 · Sep 19, 2019 · US
Peptide analogs of alpha-melanocyte stimulating hormone
US-10385108-B2 · Aug 20, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/685?
- CPC C07K14/685 is the Cooperative Patent Classification code for “Alpha-melanotropin.”
- How many patents are filed under CPC C07K14/685 (Alpha-melanotropin)?
- Our database includes 53 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/685 growing?
- Publication counts under this code: 1 in 2024 vs 2 in 2025 (latest complete years).